Case Reports in Critical Care

Case Reports in Critical Care / 2019 / Article

Case Report | Open Access

Volume 2019 |Article ID 5740503 | 5 pages | https://doi.org/10.1155/2019/5740503

Use of Direct Hemoperfusion with Polymyxin B-Immobilized Fiber for the Treatment of Septic Shock Complicated with Lemierre Syndrome Caused by Fusobacterium necrophorum

Academic Editor: Chiara Lazzeri
Received16 Feb 2019
Accepted17 Jun 2019
Published30 Jul 2019

Abstract

We report a case of septic shock treated with PMX-DHP that was complicated with Lemierre syndrome caused by Fusobacterium necrophorum. The patient was a 31-year-old man who was initially diagnosed with influenza. He received treatment; however, because his symptoms gradually worsened, he was transported to our hospital 10 days following his diagnosis. His initial examination revealed symptoms of respiratory distress and an altered level of consciousness. Based on laboratory and imaging results, it became clear that he suffered from septic shock of unknown etiology, disseminated intravascular coagulation, and acute renal and respiratory failure. We initiated treatment with vasopressors, an antibacterial agent, immunoglobulins as well as an appropriate ventilator management; however, his unstable circulatory condition continued. As soon as PMX-DHP was initiated, 2 days following admission to the ICU, his circulatory instability normalized. F. necrophorum was ultimately detected after a culture examination, and contrast-enhanced computed tomography revealed a jugular vein thrombus, which led to the diagnosis of Lemierre syndrome. The patient’s condition gradually improved, and he was discharged from the ICU after 19 days.

1. Introduction

Fusobacterium spp. is an anaerobic gram-negative bacillus present in the oral cavity and gastrointestinal tract [1, 2]. However, this organism rarely causes Lemierre syndrome with thrombophlebitis of the internal jugular vein in healthy young individuals [3]. Although the incidence rate has recently been reported to be 0.6–2.3 cases per million [4], the mortality rate is as high as 4–22% [5]. In this study, we report a case of polymyxin B-immobilized fiber column direct hemoperfusion for the treatment of septic shock complicated with Lemierre syndrome caused by F. necrophorum.

2. Case Presentation

A 31-year-old man, with no significant medical history, presented with a chief complaint of fever and altered level of consciousness. On April XX, 2018, cold symptoms first appeared. He was diagnosed with influenza by the family physician, and was treated with oseltamivir. However, the symptoms progressed, and it became difficult for him to move after 10 days; therefore, he was admitted to our hospital. His initial examination revealed symptoms of respiratory distress and altered consciousness. Based on blood tests and imaging, he was diagnosed with septic shock of unknown origin. Furthermore, disseminated intravascular coagulation and acute renal and respiratory failure complicated his course, and he was admitted to the ICU.

Upon admission to the ICU, the patient was 183 cm tall and weighed 65.1 kg. He had a Glasgow Coma Scale score of E4V4M6, pulse rate of 130 bpm, blood pressure of 60/45 mmHg, respiratory rate of 30/min, SpO2 of 93% on 10 L O2, and fever of 39.6°C. There was no apparent swelling or redness in the neck. Physical examination revealed that heart sounds were normal and moist rales were detected in the lungs, but there were no anomalies in the abdomen, limbs, or skin.

Multiple nodular shadows and infiltrates were observed in both lung fields on chest X-ray. Chest computed tomography (CT) revealed cavitary lesions in both lung fields, and the nodules primarily occurred under the pleura (Figure 1(a) and 1(b)). A bilateral pleural effusion was noted. The ejection fraction was 63% on transthoracic cardiac ultrasound examination. Wall motion was normal and no obvious vegetations were observed. There were no irregular findings on head and abdominal CT.

Laboratory findings upon admission are given in Table 1 and include the following: WBC: 17880/µL; BUN: 85.1 mg/dL; Cre: 2.76 mg/dL; Platelet count: 24000/µL; CRP: 25.75 mg/dL; P-SEP: 3551.0 pg/mL; PCT: 77.21 ng/mL; Endotoxin: 29.1 pg/mL; PT-INR: 1.52; DD: 1.9 µg/mL, AT3: 58%; HbA1C: 5.8%; Glu: 121 mg/dL; arterial blood gas (10 L oxygenated reservoir) pH: 7.509; pO2: 73.9 mmHg; pCO2: 26.9 mmHg; : 20.5 mol/L; BE: −0.2 mmol/L; Lactate: 3.4 mmol/L; Influenza test: A(−), B(−), and HIV: (−); Sequential organ failure assessment score: 15; Acute physiology and chronic health evaluation II (APACHE II) score: 32; and Acute DIC score: 5.


Hematology
WBC17880/μL
RBC3.54 million/μL
Hb11.5 g/dL
Hct32.9%
Plt24000/μL

Coagulation tests
PT19%
PT-INR1.52
APTT43.9 s
D-dimer1.9 μg/mL
AT358%

Biochemistry
AST66 U/L
ALT46 U/L
LDH472 U/L
γ-GTP36 U/L
T-BIL4 mg/dL
D-BIL3.1 mg/dL
CK107 U/L
TP5.1 g/dL
Alb2 g/dL
BUN85.1 mg/dL
Cre2.76 mg/dL
Na128 mEq/L
K3.7 mEq/L
Cl89 mEq/L

Serology
CRP25.75 mg/dL
Presepsin3551 pg/mL
Procalcitonin77.21 ng/mL
Endotoxin29.1 pg/mL
β-D glucan≦5.0 pg/mL
HbA1C5.8%
Glu121 mg/dL
HBs-Ag(−)
HCV-Ab(−)
HIV(−)

Arterial blood gases
(10 L reservoir oxygen)
pH7.509
pCO226.9 mmHg
pO273.9 mmHg
20.5 mEq/L
BE−0.2 mEq/L
Lac3.4 mmol/L

Urinalysis
Pneumococcal-Ag(−)
Legionella-Ag(−)

Influenza
Type A(−)
Type B(−)

Acid-fast
Smear(−)
Culture(−)

Culture
Sputum and blood
Fusobacterium necrophorum

MIC of F. necrophorum

AntibioticsMIC

Ampicillin0.12S
Penicillin G0.06S
Sulbactam/ampicillin≦0.06S
Cefmetazole≦1S
Meropenem≦0.25S
Levofloxacin≦2S
Clindamycin≦0.12S
Tazobactam/piperacillin≦16S

The patient’s post-hospitalization course is given in Figure 2. Upon admission to the ICU, he was intubated and placed on a ventilator. Based on Sepsis-3 [6], he was diagnosed with septic shock, and we administered a continuous infusion of noradrenaline (NAD). Although the infection source and causative bacterial species were unknown, the likelihood of the presence of an endotoxin was high; therefore, tazobactam/piperacillin and levofloxacin were administered. Antithrombin and gabexate mesylate were administered for septic DIC. Despite a high dose of NAD, circulatory insufficiency remained significant; 2 days after admission to the ICU, PMX-DHP (PMX-20R) was administered for about 3 h. His blood pressure began to immediately rise; once his blood pressure was stable, about 3 h after initiation of the infusion, the dosage of NAD was gradually decreased.

F. necrophorum (Table 1) was detected in the blood culture on the 6th day after admission to the ICU. On the same day, cervical contrast-enhanced CT, neck echocardiography, and intraoral examination were performed. Cervical contrast-enhanced CT and neck echocardiography revealed a thrombus in the right internal and external jugular veins, and emboli were present in both lung fields on chest CT (Figure 1(c)). Intraoral examination revealed periodontal disease and multiple caries in the oral cavity (Figure 1(d)). These findings led to the diagnosis of Lemierre syndrome caused by F. necrophorum. With continued oral care and antimicrobial treatment, his respiratory condition gradually improved, and he was removed from the ventilator on the 16th day after admission to the ICU, and moved to the general ward on the 20th day.

3. Discussion

In Lemierre syndrome, thrombophlebitis of the internal jugular vein is caused by acute pharyngitis and abscess in the amygdala. In severe cases, bacterial emboli from the internal jugular vein spread to the lung, liver, kidney, bone, and joints. Lemierre syndrome is more common in healthy young individuals, and the male- to-female ratio was 1 : 2 [7]. In addition, among the 114 cases of Lemierre syndrome, it has been reported that the proportion of the 1st decade to 3rd decade was 79% [7]. Even in this case, it was an inherently healthy young person.

Notably, F. necrophorum has been identified as the causative species in at least 80% of patients with Lemierre syndrome [8]. In our case, in addition to periodontitis and numerous dental caries, pharyngitis caused by the influenza virus may have triggered the onset of the syndrome. Furthermore, the infection route is consistent with that reported previously [9, 10].

Lemierre syndrome is characterized by (1) a history of recent oropharyngeal infection, (2) clinical or radiological evidence of internal jugular vein thrombosis, and (3) isolation of anaerobic pathogens, mainly Fusobacterium necrophorum [11]. The patient did fulfill these characteristics.

For several days after admission to the ICU, although the infection source and causative bacterial species were unknown, the endotoxin levels were high, and intensive care was provided based on the presumed diagnosis of septic shock from gram-negative bacteria. We believe that the initial treatment was appropriate because it took 6 days before the culture was positive for F. necrophorum; this suggests the diagnosis of Lemierre syndrome. To the best of our knowledge, this is the first report of PMX-DHP being used for the successful treatment of septic shock with Lemierre syndrome caused by F. necrophorum. In our case, the endotoxin level decreased from 6.8 pg/mL before PMX-DHP infusion to 2.6 pg/mL after infusion. In addition, his blood pressure was quite unstable prior to PMX-DHP infusion, with 74/44 mmHg before infusion to 113/47 mmHg after infusion, after which it stabilized. As a result, the infusion of NAD could be gradually decreased from 0.23 µg/kg/min to 0.08 µg/kg/min. F. necrophorum tends to form a septic thrombus by destroying red blood cells and aggregating platelets and bacteria by producing endotoxins [12]. Therefore, PMX-DHP was considered to be effective based on this mode of action.

We describe a report in which PMX-DHP was used for the treatment of septic shock complicated with Lemierre syndrome caused by F. necrophorum. In addition to the early use of appropriate antimicrobial therapy, PMX-DHP should be considered a supportive therapy in similar situations.

This is an anonymous case report based on the Personal Information Protection Law, and the consent for publication was obtained from the patient and his family.

Conflicts of Interest

The authors declare no conflicts of interest associated with this manuscript.

References

  1. K. W. Bennett and A. Eley, “Fusobacteria: new taxonomy and related diseases,” Journal of Medical Microbiology, vol. 39, no. 4, pp. 246–254, 1993. View at: Publisher Site | Google Scholar
  2. J. Frias-Lopez and A. Duran-Pinedo, “Effect of periodontal pathogens on the metatranscriptome of a healthy multispecies biofilm model,” Journal of Bacteriology, vol. 194, no. 8, pp. 2082–2095, 2012. View at: Publisher Site | Google Scholar
  3. A. Lemierre, “On certain septicemias due to anaerobic organisms,” The Lancet, vol. 227, no. 5874, pp. 701–703, 1936. View at: Publisher Site | Google Scholar
  4. M. I. Syed, D. Baring, M. Addidle, C. Murray, and C. Adams, “Lemierre syndrome: two cases and a review,” Laryngoscope, vol. 117, no. 9, pp. 1605–1610, 2007. View at: Publisher Site | Google Scholar
  5. W. F. Wright, C. N. Shiner, and J. A. Ribes, “Lemierre syndrome,” Southern Medical Journal, vol. 105, no. 5, pp. 283–288, 2012. View at: Publisher Site | Google Scholar
  6. M. Singer, C. S. Deutschman, C. W. Seymour et al., “The third international consensus definitions for sepsis and septic shock (sepsis-3),” Journal of the American Medical Association, vol. 315, no. 8, pp. 801–810, 2016. View at: Publisher Site | Google Scholar
  7. P. D. Karkos, S. Asrani, C. D. Karkos et al., “Lemierre's syndrome: a systematic review,” Laryngoscope, vol. 119, no. 8, pp. 1552–1559, 2009. View at: Publisher Site | Google Scholar
  8. C. P. Sinave, G. J. Hardy, and P. W. Fardy, “The Lemierre syndrome: suppurative thrombophlebitis of the internal jugular vein secondary to oropharyngeal infection,” Medicine, vol. 68, no. 2, pp. 85–94, 1989. View at: Publisher Site | Google Scholar
  9. M. Oya, T. Tanimoto, T. Yamamoto, and Y. Hakozaki, “Lemierre's syndrome associated with periodontal injury-derived odontogenic infection that did not respond to meropenem,” Internal Medicine, vol. 54, no. 14, pp. 1803–1808, 2015. View at: Publisher Site | Google Scholar
  10. V. Porquet-Bordes, E. Guillet, B. Cammas, and C. Runel-Belliard, “Lemierre syndrome and influenza A (H1N1),” Archives of Pediatrics, vol. 18, no. 4, pp. 413–415, 2011. View at: Publisher Site | Google Scholar
  11. P. Bondy and T. Grant, “Lemierre's syndrome: what are the roles for anticoagulation and long-term antibiotic therapy?” Annals of Otology, Rhinology & Laryngology, vol. 117, no. 9, pp. 679–683, 2008. View at: Publisher Site | Google Scholar
  12. R. Golpe, B. Marín, and M. Alonso, “Lemierre's syndrome (necrobacillosis),” Postgraduate Medical Journal, vol. 75, no. 881, pp. 141–144, 1999. View at: Publisher Site | Google Scholar

Copyright © 2019 Yoshiyuki Kodama et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

517 Views | 260 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.